Obagi Expands Product Line with Clenziderm for Acne
Obagi has introduced a new product to aid in the fight against acne - CLENZIderm M.D.™ Acne Therapeutic System. This new product is the first to be infused with the groundbreaking liquefied 5% benzoyl peroxide technology that delivers astonishing results.
The CLENZIderm M.D.™ Acne Kit is the first of its kind to effectively treat all three causes of acne. It quickly gets rid of excess sebum, skin cell buildup, and Proprionibacterium acnes bacteria. After a 3 week clinical study, CLENZIderm M.D.™ provided a reduction in sore red acne by 62% and a reduction in blackheads and whiteheads by 47%.
The secret is behind Obagi's patented Soluzyl Technology™ which converts the active ingredient of Benzoyl Peroxide into a liquid upon contact with the skin. By becoming a liquid on contact, the solution is able to penetrate deeper into the pores and provide rapid acne lesion reduction. This new acne solution could mean a complete transformation in acne products and ingredients. Most acne solutions are only able to clean the surface of the skin. Benzoyl Peroxides are typically formulated with insoluble macro-crystals. These macro-crystals are too big to dig deep into the pores which results in only cleansing the surface of the skin. Obagi's patented Soluzyl Technology™ liquefies these macro-crystals to allow them to clean deeper into the pores.
Obagi boasted during the unveiling of the results from their clinical trials. They emphasized that the use of CLENZIderm M.D.™ shows follicular acne reduction as quickly as eight hours. Their findings also show a 52% reduction in inflammatory lesions and a 34% reduction in non-inflammatory lesions in two weeks.
Obagi's CLENZIderm M.D.™ Acne Therapeutic System is an amazing advancement in skin care - one that may revolutionize your skin to looking cleaner and better.
For more information, visit prskincare.com
The CLENZIderm M.D.™ Acne Kit is the first of its kind to effectively treat all three causes of acne. It quickly gets rid of excess sebum, skin cell buildup, and Proprionibacterium acnes bacteria. After a 3 week clinical study, CLENZIderm M.D.™ provided a reduction in sore red acne by 62% and a reduction in blackheads and whiteheads by 47%.
The secret is behind Obagi's patented Soluzyl Technology™ which converts the active ingredient of Benzoyl Peroxide into a liquid upon contact with the skin. By becoming a liquid on contact, the solution is able to penetrate deeper into the pores and provide rapid acne lesion reduction. This new acne solution could mean a complete transformation in acne products and ingredients. Most acne solutions are only able to clean the surface of the skin. Benzoyl Peroxides are typically formulated with insoluble macro-crystals. These macro-crystals are too big to dig deep into the pores which results in only cleansing the surface of the skin. Obagi's patented Soluzyl Technology™ liquefies these macro-crystals to allow them to clean deeper into the pores.
Obagi boasted during the unveiling of the results from their clinical trials. They emphasized that the use of CLENZIderm M.D.™ shows follicular acne reduction as quickly as eight hours. Their findings also show a 52% reduction in inflammatory lesions and a 34% reduction in non-inflammatory lesions in two weeks.
Obagi's CLENZIderm M.D.™ Acne Therapeutic System is an amazing advancement in skin care - one that may revolutionize your skin to looking cleaner and better.
For more information, visit prskincare.com
Labels: acne prevention
posted by Ron King | 2:39 PM
<< Home